Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 114M | 116M | 65M | 83M |
Cost of revenue | 8M | 9M | 6M | 9M |
Gross profit | 106M | 107M | 59M | 74M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 35M | 43M | 27M | 33M |
Operating income | 1M | 5M | -18M | 85M |
Non operating interest income | ||||
Income | 5M | 11M | 5M | 8M |
Expense | 21M | 31M | 17M | 20M |
Other income expense | — | — | — | — |
Pretax income | -9M | 9M | -20M | 124M |
Tax provision | 0 | 13M | -2M | 0 |
Net income | -8M | -4M | -17M | 125M |
Basic EPS | -0.1 | -0.1 | -0.1 | 0.4 |
Diluted EPS | -0.1 | -0.1 | -0.1 | 0.4 |
Basic average shares | 283.3M | 266.7M | 316.7M | 288.1M |
Diluted average shares | 283.3M | 266.7M | 316.7M | 288.1M |
EBITDA | 54M | 82M | 39M | 189M |
Net income from continuing op. | -9M | 9M | -20M | 125M |
Minority interests | -9M | -12M | -1M | -4M |
Preferred stock dividends | 0 | 0 | 0 | 0 |